Centre for Personalised Analysis of Cancers (CPAC)
The objectives of our inter-disciplinary program are to optimise, expand and exploit current capabilities to:
(i) Facilitate the development of advanced patient-derived 3D tumour models (tumouroids and explants) in which to undertake ex-vivo therapeutic sensitivity screens;
(ii) Identify specific ex-vivo assays that reliably read-out clinical responses and test their utility in clinical trials;
(iii) Provide a structured, coordinated, interdisciplinary and tumour-stream aligned research training program for early career clinicians; and
(iv) Instigate a coordinated consumer collective of tumour stream representatives with high level representation across CPAC committees to facilitate consumer input.
Investigators
| Prof Rik Thompson | IHBI, QUT |
| A/Prof Elizabeth Williams | APCRC-Q, IHBI, QUT |
| Prof Colleen Nelson | APCRC-Q, IHBI, QUT |
| Dr Ian Vela | APCRC-Q, IHBI, QUT, PAH |
| Dr Jennifer Gunter | APCRC-Q, IHBI, QUT |
| A/Prof Jyotsna Batra | APCRC-Q, IHBI, QUT |
| A/Prof Derek Richard | APCRC-Q, IHBI, QUT |
| Prof Ken O'Byrne | APCRC-Q, IHBI, QUT, PAH |
| A/Prof Mike Doran | APCRC-Q, IHBI, QUT |
| + 50 other investigators |
Duration
2019 - 2021
Funding
| Medical Research Future Fund through Brisbane Diamantina Health Partners Rapid Applied Research Translation | $1,024,080 |
